Small study, big results for Type I diabetes.
“Zimislecel is an allogeneic stem cell–derived islet-cell therapy. … Ten of the 12 participants (83%) had insulin independence and were not using exogenous insulin at day 365.” ~ learn more
“Zimislecel is an allogeneic stem cell–derived islet-cell therapy. … Ten of the 12 participants (83%) had insulin independence and were not using exogenous insulin at day 365.” ~ learn more